J2355 — Injection, oprelvekin, 5 mg
HCPCS/CPT
Prior Authorization
No Prior Auth Required
Code is covered without prior authorization (high confidence)
Medicare Pricing
Work RVU
0.00
Facility
N/A
Non-Facility
N/A
Documentation Required
- For NB-UVB: documentation of phototherapy course, frequency (2–3 times per week) and cumulative number of treatments (UpToDate cited up to 200 treatments for some courses).
- For excimer laser: documentation of treatment frequency and number of sessions (typically twice weekly; up to 60 treatments may generally be medically necessary for excimer laser).
- Documentation of diagnosis: ICD-10 L80 (vitiligo) when submitting claims for covered therapies.
- No explicit documentation requirements are specified in the provided document text (selection criteria are referenced but not detailed in this excerpt)
Key Coverage Criteria
- Surgical epidermal grafting / epidermal harvesting techniques (including automated suction blister epidermal graft [SBEG] devices and other epidermal harvesting systems) have been used for stable localized vitiligo and may be effective in patients with stable vitiligo unresponsive to standard therapies.
- Fractional CO2 laser in combination with topical tacrolimus may be an effective adjunctive therapy for some patients (especially progressing disease per the cited preliminary studies).
- Combination therapies with NB-UVB plus adjuncts (e.g., topical tacrolimus, needling/micro-needling, Er:YAG laser + topical 5% 5-FU, betamethasone intramuscular injection, carboxytherapy, certain Chinese herbal compounds) have been reported to be more effective than NB-UVB alone in some trials / meta-analyses.
- ICD-10 diagnosis covered if selection criteria are met: L80 (Vitiligo).
- Treatment of vitiligo using the following established methods: Excimer laser (e.g., XTRAC, PhotoMedex, Radnor, PA; EX-308, Ra Medical Systems, Inc., Carlsbad, CA).
- Treatment of vitiligo using Narrow-band ultraviolet B (NB-UVB).
1 Active Policy
AETNA-CPB-0422 — Vitiligo
Related Codes
Have a follow-up question?
Ask Verity about documentation requirements, denial risks, or coverage in your state.